ANEBULO PHARMACEUTICALS, INC. (ANEB) Operating income 2021–2025
ANEBULO PHARMACEUTICALS, INC. (ANEB) annual operating income history from SEC filings — each fiscal year as reported.
-$9.2MFY2025 · since FY2021: -$3.6M → -$9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.2M | -11.0% |
| FY2024 | -$8.3M | +29.5% |
| FY2023 | -$11.8M | -72.5% |
| FY2022 | -$6.8M | -89.0% |
| FY2021 | -$3.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANEB financial trends
ANEB RevenueANEB Net incomeANEB Net marginANEB Gross profitANEB Gross marginANEB Operating marginANEB Operating cash flowANEB Free cash flowANEB Capital expendituresANEB Return on equityANEB Stock buybacksANEB Dividends paidANEB Total assetsANEB Total liabilitiesANEB Shareholders’ equityANEB overview →